Anne-Marie Landtblom
Professor emeritus at Institutionen för medicinska vetenskaper; Neurologi
- Telephone:
- +46 18 611 50 31
- Mobile phone:
- +46 70 559 16 70
- E-mail:
- anne-marie.landtblom@neuro.uu.se
- Visiting address:
- Akademiska sjukhuset
- Postal address:
- Akademiska sjukhuset, ing 85 plan 2
751 85 UPPSALA
- Academic merits:
- MD PhD
More information is available to staff who log in.
Short presentation
Professor in neurology, with specialities MS, sleep disorders and epilepsy. Also active at University of Linköping incl. CMIV, imaging center, with a focus on MRI research on narcolepsy, Kleine Levin syndrome, epilepsy and MS. Activitities in national registers: The Swedish neuroregister especially The Swedish narcolepsy register. Epidemiologic research, esp. on MS, for example in the multinational study ENVIMS and studies of the gender ratio.
Publications
Recent publications
- Characterization of the Increase in Narcolepsy following the 2009 H1N1 Pandemic in Sweden (2024)
- Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study (2024)
- Inventory study of an early pandemic COVID-19 cohort in South-Eastern Sweden, focusing on neurological manifestations (2023)
- A comprehensive diagnostic approach in suspected neurosarcoidosis (2023)
- Shift workers are at increased risk of severe COVID-19 compared with day workers (2023)
All publications
Articles
- Characterization of the Increase in Narcolepsy following the 2009 H1N1 Pandemic in Sweden (2024)
- Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study (2024)
- Inventory study of an early pandemic COVID-19 cohort in South-Eastern Sweden, focusing on neurological manifestations (2023)
- A comprehensive diagnostic approach in suspected neurosarcoidosis (2023)
- Shift workers are at increased risk of severe COVID-19 compared with day workers (2023)
- The association of insomnia with long COVID (2023)
- Case report (2023)
- The Importance of Optical Coherence Tomography in the Diagnosis of Atypical or Subclinical Optic Neuritis (2023)
- Absence of Oligoclonal Bands in Multiple Sclerosis (2023)
- Associations between changes in habitual sleep duration and lower self-rated health among COVID-19 survivors (2023)
- Sleep symptoms are essential features of long-COVID (2023)
- Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II) (2023)
- Association between hypersomnolence and the COVID-19 pandemic (2023)
- Persistent short nighttime sleep duration is associated with a greater post-COVID risk in fully mRNA-vaccinated individuals. (2023)
- Similar Profile and Magnitude of Cognitive Impairments in Focal and Generalized Epilepsy (2022)
- Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination (2022)
- Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci (2021)
- Multiple sclerosis and COVID-19 (2021)
- Immunocyte single cell analysis of vaccine-induced narcolepsy (2021)
- Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease (2021)
- Ecstatic and gelastic seizures related to the hypothalamus (2021)
- Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County (2021)
- Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis (2021)
- The cost-utility of pitolisant as narcolepsy treatment. (2020)
- Aniridia with PAX6 mutations and narcolepsy (2020)
- Ecstatic and gelastic seizures relate to the hypothalamus (2020)
- Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms (2019)
- Structural anomaly in the reticular formation in narcolepsy type 1, suggesting lower levels of neuromelanin (2019)
- Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival (2019)
- Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects (2019)
- RebiQoL (2019)
- Organic solvent exposure as a risk factor for multiple sclerosis (2019)
- Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden (2018)
- Increased risk of MS after organic solvent exposure (2018)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5) (2018)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4) (2018)
- Neuroimaging in the Kleine-Levin Syndrome (2018)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2) (2018)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3) (2018)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1) (2018)
- Unexpected Fat Distribution in Adolescents With Narcolepsy. (2018)
- Physical Activity Is Associated With A Decreased Multiple Sclerosis Risk (2018)
- Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis (2018)
- Evidence for cognitive resource imbalance in adolescents with narcolepsy (2018)
- Cerebellar ataxia and intrathecal baclofen therapy (2017)
- Negative interaction between smoking and EBV in the risk of multiple sclerosis (2017)
- Patterns of antiepileptic drug prescription in Sweden (2017)
- Narcolepsy as a side effect of swine flu vaccination (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5) (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4) (2017)
- Hereditary cerebellar ataxia and intrathecal baclofen (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of natalizumab (IMSE 1) (2017)
- RebiQoL (2017)
- The diagnosis of OCB-negative MS-patients - an inventory of the Swedish MS register in Uppsala, Sweden (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2) (2017)
- A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3) (2017)
- Tau or neurofilament light - Which is the more suitable biomarker for Huntington’s disease? (2017)
- Corpus callosum atrophy in MS is halted by autologous haematopoietic stem cell transplantation (2017)
- Rituximab in multiple sclerosis; data from the swedish MS registry. (2016)
- Adverse events of rituximab in a Swedish MS population sample. (2016)
- Altered Brain Microstate Dynamics in Adolescents with Narcolepsy (2016)
- New hypothesis on pontine-frontal eye field connectivity in Kleine-Levin syndrome (2016)
- Real world experience of fingolimod after switching multiple sclerosis (MS) therapy; focus on natalizumab naive and experienced persons with MS, respectively (2016)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5) (2016)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of natalizumab (IMSE 1) (2016)
- Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data (2016)
- Prevalence and cost of epilepsy in Sweden - (2015)
- Does the changing sex ratio of multiple sclerosis give opportunities for intervention? (2015)
- Evidence of Conjoint Activation of the Anterior Insular and Cingulate Cortices during Effortful Tasks (2015)
- A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of dimethyl fumarate (2015)
- Being parents with epilepsy (2015)
- Genetic load in eleven distantly related individuals from an MS high risk area (2015)
- A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab (2015)
- The IMSE 2 study (2015)
- Brain circuitries involved in sleep disorders (2015)
- The EnvIMS Study (2015)
- Antiepileptic drugs and intrauterine death (2015)
- Body size and the risk of multiple sclerosis in Norway and Italy (2015)
- Sun exposure and multiple sclerosis risk in Norway and Italy (2014)
- Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden (2014)
- Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg) (2014)
- Functional magnetic resonance imaging in narcolepsy and the Kleine-Levin syndrome (2014)
- Thalamic activation in the Kleine-Levin syndrome (2014)
- Reduced thalamic and pontine connectivity in kleine-levin syndrome (2014)
- Multi-parametric representation of voxel-based quantitative magnetic resonance imaging (2014)
- Epilepsy and violence (2014)
- Narkolepsi – ovanlig sjukdomsom fått ökad uppmärksamhet (2014)
- A Swedish nationwide pharmaco-epidemiological and genetic study (IMSE) of the long-term safety and efficacy of natalizumab (2014)
- The sleepy teenager (2014)
- Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; (2014)
- Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate (2014)
- SPECT in the Kleine-Levin Syndrome, a Possible Diagnostic and Prognostic Aid? (2014)
- Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis (2014)
- Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR (2014)
- New data identify an increasing sex ratio of multiple sclerosis in Sweden (2014)
- A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies (2014)
- Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg) (2013)
- Thalamo-striato-cortical determinants to fatigue in multiple sclerosis (2013)
- Brain and effort (2013)
- Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue (2013)
- Impaired language function in generalized epilepsy (2013)
- Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans (2013)
- Low thalamic NAA-concentration corresponds to strong neural activation in working memory in Kleine-Levin syndrome (2013)
- Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden (2012)
- Bent spine syndrome (2012)
- Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis (2012)
- A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q) (2012)
- CSF Proenkephalin decreases with the progression of Huntington's disease
- Cerebral blood flow in multiple sclerosis: an 15O-water PET study
- Lifestyle factors and gender-related differences in clinical subgroups of Myasthenia Gravis in southern Sweden
